- Report
- June 2024
- 52 Pages
North America
From €5384EUR$5,995USD£4,611GBP
- Report
- June 2024
- 66 Pages
Europe
From €5384EUR$5,995USD£4,611GBP
- Report
- June 2024
- 69 Pages
Asia Pacific
From €5384EUR$5,995USD£4,611GBP
- Report
- June 2024
- 30 Pages
United States
From €4486EUR$4,995USD£3,842GBP
- Report
- June 2024
- 51 Pages
China
From €988EUR$1,100USD£846GBP
- Report
- September 2018
- 233 Pages
Global
From €3592EUR$4,000USD£3,077GBP
- Report
- March 2020
- 82 Pages
Global
From €808EUR$900USD£692GBP
- Report
- February 2021
- 144 Pages
Global
From €2470EUR$2,750USD£2,115GBP
- Report
- August 2019
Global
€2649EUR$2,950USD£2,269GBP
- Report
- April 2024
- 95 Pages
Global
From €4445EUR$4,950USD£3,807GBP
- Report
- October 2021
- 75 Pages
Global
From €4445EUR$4,950USD£3,807GBP
- Report
- June 2024
- 145 Pages
Global
From €2245EUR$2,500USD£1,923GBP
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- November 2023
- 178 Pages
Global
From €3435EUR$3,825USD£2,942GBP
€4041EUR$4,500USD£3,461GBP
- Report
- August 2023
- 78 Pages
Israel
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- August 2023
- 79 Pages
Canada
From €2672EUR$2,975USD£2,288GBP
€3143EUR$3,500USD£2,692GBP
- Report
- February 2024
- 70 Pages
Europe
From €4266EUR$4,750USD£3,654GBP
- Report
- April 2023
- 115 Pages
Global
From €4266EUR$4,750USD£3,654GBP
- Report
- April 2023
- 110 Pages
United Kingdom
From €4266EUR$4,750USD£3,654GBP
- Report
- April 2023
- 80 Pages
South Korea
From €4266EUR$4,750USD£3,654GBP

The Cardiac Valve market is a segment of the Cardiovascular Devices industry, which includes a range of products used to diagnose and treat heart conditions. Cardiac valves are used to regulate the flow of blood through the heart, and can be either mechanical or biological. Mechanical valves are typically made of metal and are designed to last for many years, while biological valves are made of animal tissue and are designed to be replaced over time. Both types of valves are used to treat a variety of heart conditions, including aortic stenosis, mitral regurgitation, and tricuspid regurgitation.
The Cardiac Valve market is highly competitive, with a number of companies offering a range of products. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. Other companies in the market include CryoLife, Symetis, and Neovasc. Show Less Read more